Anna Lyakisheva
Impact in
-
- Pluripotent Stem Cells Research
- CRISPR and Genetic Engineering
- Epigenetics and DNA Methylation
- Protein Degradation and Inhibitors
- Ubiquitin and proteasome pathways
-
- Mesenchymal stem cell research
Papers in
-
- Protein Degradation and Inhibitors 4
- Ubiquitin and proteasome pathways 4
- Oncology 4
- Cancer-related Molecular Pathways 1
- Co-authors
- Igor Štagljar (7 shared papers)Jamie Snider (3 shared papers)Victoria Wong (2 shared papers)Punit Saraon (1 shared paper)Pavel Volchkov (2 shared papers)С. Л. Киселев (2 shared papers)Maria A. Lagarkova (2 shared papers)Zhong Yao (3 shared papers)
In The Last Decade
Anna Lyakisheva
11 papers receiving 292 citations
Peers
Comparison fields: 5 of 60
- Molecular Biology 211
- Genetics 23
- Oncology 45
- Immunology 31
- Nephrology 9
Countries citing papers authored by Anna Lyakisheva
This map shows the geographic impact of Anna Lyakisheva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Lyakisheva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Lyakisheva more than expected).
Fields of papers citing papers by Anna Lyakisheva
This network shows the impact of papers produced by Anna Lyakisheva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Lyakisheva. The network helps show where Anna Lyakisheva may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Lyakisheva, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 121 | |
| 2 | 2006 | 73 | |
| 3 | 2020 | 35 | |
| 4 | 2021 | 19 | |
| 5 | 2022 | 17 | |
| 6 | 2002 | 15 | |
| 7 | 2021 | 9 | |
| 8 | 2006 | 6 | |
| 9 | 2024 | 2 | |
| 10 | 2018 | 1 | |
| 11 | 2020 | 1 |
About Anna Lyakisheva
Anna Lyakisheva is a scholar working on Molecular Biology, Oncology, Radiology, Nuclear Medicine and Imaging, Infectious Diseases and Nephrology, having authored 11 papers that have together received 299 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (4 papers), Ubiquitin and proteasome pathways (4 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Telomeres, Telomerase, and Senescence (1 paper), Renal Diseases and Glomerulopathies (1 paper), Mesenchymal stem cell research (1 paper), Cancer-related Molecular Pathways (1 paper) and SARS-CoV-2 and COVID-19 Research (1 paper). The work is most often cited by research in Molecular Biology (211 citations), Genetics (23 citations), Oncology (45 citations), Immunology (31 citations) and Nephrology (9 citations). Anna Lyakisheva has collaborated with scholars based in Canada, Croatia and Russia. Frequent co-authors include Igor Štagljar, Jamie Snider, Victoria Wong, Punit Saraon, Pavel Volchkov, С. Л. Киселев, Maria A. Lagarkova, Zhong Yao, Priscilla Tang and Max Kotlyar. Their work appears in journals such as Nature Communications, Experimental Hematology, Molecular Cancer Research, Cell Cycle and Journal of Molecular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.